台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

Emerging Roles of PSMA Based Diagnostics and Therapeutics in Prostate Cancer_Raj Tiwari

2025-03-14 • 觀看: 24 • 回應: 0 • embed
Unveiling EV+P's potential: EV-302 Asian Subgroup and Real-World Outcome in CGMH-KH_劉惠瑛

2025-03-14 • 觀看: 16 • 回應: 0 • embed
A New Era in La/mUC: How EV302 Transforms First-Line Therapy for Urothelial Cancer_Ignacio Durán

2025-03-14 • 觀看: 25 • 回應: 0 • embed
Surgical Management of NLUTD in Chronic SCI Patients_范玉華

2025-02-19 • 觀看: 9 • 回應: 0 • embed
Urinary diversion and urinary tract reconstruction – augmentation, ileal interposition, neobladder urodynamics_郭漢崇

2025-02-19 • 觀看: 2 • 回應: 0 • embed
Pharmacological Treatment of NLUTD in Chronic SCI Patients_陳聖復

2025-02-19 • 觀看: 8 • 回應: 0 • embed
Nocturia and nocturnal polyuria – evaluation, diagnosis, and appropriate management_郭漢崇

2025-02-19 • 觀看: 6 • 回應: 0 • embed
Videourodynamic study interpretation of LUTD and selecting appropriate medications based on VUDS findings_郭漢崇

2025-02-19 • 觀看: 2 • 回應: 0 • embed
20231109 Management of LUTS in patients with neurogenic disorders_郭漢崇

2025-02-19 • 觀看: 9 • 回應: 0 • embed
TSH-2 Therapies for NMIBC beyond Bacillus Calmette-Guérin_楊明昕

2025-02-18 • 觀看: 4 • 回應: 0 • 影片
TSH-3 What’s next after immune-based therapy for advanced RCC?_呂育全

2025-02-18 • 觀看: 5 • 回應: 0 • 影片
TSH-1 PSMA-based therapies for advanced prostate cancer, combination or sequence?_林柏宏

2025-02-18 • 觀看: 10 • 回應: 0 • 影片

Prev
222
223
224
225
226
227
228
229
230
231
Next
/ 1264